Adaptive Biotechnologies Files 8-K on Shareholder Vote
Ticker: ADPT · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1478320
| Field | Detail |
|---|---|
| Company | Adaptive Biotechnologies Corp (ADPT) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: ADPT
TL;DR
Adaptive Bio shareholders voted on something important June 10th, 8-K filed.
AI Summary
Adaptive Biotechnologies Corp. filed an 8-K on June 12, 2025, reporting on a matter submitted to a vote of its security holders on June 10, 2025. The filing does not disclose the specific details of the vote or the outcome.
Why It Matters
This filing indicates a significant event where shareholders voted on a corporate matter, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain information that immediately impacts the company's financial health or operations.
Key Players & Entities
- Adaptive Biotechnologies Corp. (company) — Registrant
- June 10, 2025 (date) — Date of earliest event reported
- June 12, 2025 (date) — Date of report
FAQ
What specific matter was submitted to a vote of Adaptive Biotechnologies Corp. security holders on June 10, 2025?
The filing does not specify the exact matter that was submitted for a vote.
What was the outcome of the vote by Adaptive Biotechnologies Corp. security holders?
The filing does not disclose the results or outcome of the shareholder vote.
Is this 8-K filing related to a specific corporate action like an acquisition or merger?
The filing states it is for 'Submission of Matters to a Vote of Security Holders' but does not provide details on whether it's related to an acquisition or merger.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 10, 2025.
What is the principal executive office address for Adaptive Biotechnologies Corp.?
The principal executive office is located at 1165 Eastlake Avenue East, Seattle, Washington, 98109.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Adaptive Biotechnologies Corp (ADPT).